ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease

Kidney International

Volumn 50, Issue 2, 1996, Pages 538-542

  Berg, Anna Lena ^a   Nilsson Ehle, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AZATHIOPRINE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISOLONE; STEROID; TETRACOSACTIDE ZINC PHOSPHATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN DEFICIENCY; HUMAN; HYPERLIPIDEMIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL; WEGENER GRANULOMATOSIS;

EID: 0029839797     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.346     Document Type: Article

References (15)

1. BROWN MS, GOLDSTEIN JL: Disorders of lipid metabolism, in Harrison's Principles of Internal Medicine (9th ed), edited by ISSELBACHER KJ, ADAMS AD, BRAUNWALD E, PETERSDORF RG, WILSON JD, Tokyo, McGraw-Hill, 1980, pp 507-518
2. BERG AL, HANSSON P, NILSSON-EHLE P: ACTH 1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy men. J Intern Med 229:201-203, 1991
3. BERG AL, NILSSON-EHLE P: Direct effects of ACTH on plasma lipoprotein metabolism in man-Studies in vivo and in vitro. Metabolism 43:90-97, 1994
4. NILSSON-EHLE P, EKMAN R: Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3:194-209, 1977
5. DANIELSSON B, EKMAN R, FEX G, JOHANSSON BG, KRISTENSSON H, NILSSON-EHLE P, WADSTEIN J: Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 38:113-119, 1978
6. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
7. MOORHEAD JF: Lipids and progressive kidney disease. Kidney Int 39(Suppl 31):35-40, 1991
8. OSCARSSON J, CARLSSON LMS, BICK T, LIDELL A, OLOESSON S-O, EDÉN S: Evidence for the role of the secretory pattern of growth hormone in the regulation of serum concentrations of cholesterol and apolipoprotein E in rats. J Endocrinol 128:433-438, 1991
9. VIKMAN-ADOLESSON K, OSCARSSON J, NILSSON-EHLE P, EDÉN S: Growth hormone but not gonadal steroids influences lipoprotein lipase and hepatic lipase activity in hypophysectomized rats. J Endocrinol 140:203-209, 1994
10. KEANE WF, KASISKE BL, O'DONNELL MP: Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 8:261-271, 1988
11. SCHMITZ PG, KASISKE BL, O'DONNELL MP, KLANE WF: Lipids and progressive renal injury. Semin Nephrol 9:354-369, 1989
12. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):41-48, 1991
13. DRÜEKE TB, ABDULMASSIH Z, LACOUR B, BADER C, CHEVALIER A, KREIS H: Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 39(Suppl 31):24-28, 1991
14. KASISKE BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992, 1988
15. ARNADOTTIR M, FRIKSSON LO, GERMERSHAUSEN JI, THYSELL H: Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: Double-blind, randomized, placebo-controlled study in 40 patients. Nephron 68:57-62, 1994